ArticleScientific reports2026
Survival prediction for bladder cancer using multimodal data with quantum neural networks and transformer architectures.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To address the challenges of cross-modal information fusion in high-dimensional multimodal medical data for cancer prognosis, this study presents a hybrid diagnostic accuracy model for cancer survival prediction, integrating quantum computing with classical deep learning in a retrospective analysis of bladder cancer patients. We propose QTMPN (Quantum-Transformer Multimodal Prognostic Network), a novel framework integrating quantum neural networks (QNNs), Transformers, and graph neural networks (GNNs). For high-dimensional whole-slide pathological images (WSIs), a quantum feature extractor (QFE) is designed using parallel quantum encoding and a hybrid quantum network to capture long-range dependencies. Multimodal data-including clinical and image features-are fused via a Transformer-GNN Collaborative Fusion (TCF) module employing attention-guided dynamic graphs. Evaluated on the TCGA-BLCA dataset, QTMPN attained a survival prediction accuracy of 76.1%, outperforming baseline models such as PARADIGM and CMTA (up to 70.0%). This improvement suggests the model's enhanced capability to capture cross-modal prognostic features. Further ablation experiment validated the effectiveness of the hybrid QNNs feature extract part (QFE) in QTMPN. QTMPN presents a promising quantum-classical framework for survival risk prediction in bladder cancer, effectively modeling complex multimodal interactions. The approach contributes to improving prognostic accuracy in oncology and supporting precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.